Directory | Consumers 

               
       

Hits: 32366

User Rating: 4 / 5

Star ActiveStar ActiveStar ActiveStar ActiveStar Inactive

 

Document Name PDF
Status Kelulusan Permohonan CTIL/CTX Bulan April- Disember 2020 2020
Status Kelulusan Permohonan CTIL/CTX Tahun 2021 2021
Status Kelulusan Permohonan CTIL/CTX Tahun 2022 2022
Status Kelulusan Permohonan CTIL/CTX Bulan Januari 2023 Januari 2023
Status Kelulusan Permohonan CTIL/CTX Bulan Februari 2023 Februari 2023
Status Kelulusan Permohonan CTIL/CTX Bulan Mac 2023 Mac 2023
Status Kelulusan Permohonan CTIL/CTX Bulan April 2023 April 2023
Status Kelulusan Permohonan CTIL/CTX Bulan Mei 2023 Mei 2023
Status Kelulusan Permohonan CTIL/CTX Bulan Jun 2023 Jun 2023
Status Kelulusan Permohonan CTIL/CTX Bulan Julai 2023 Julai 2023
Status Kelulusan Permohonan CTIL/CTX Bulan Ogos 2023 Ogos 2023
Status Kelulusan Permohonan CTIL/CTX Bulan September 2023 Sept 2023
Status Kelulusan Permohonan CTIL/CTX Bulan Oktober 2023 Oktober 2023

 

 

Hits: 282828

User Rating: 3 / 5

Star ActiveStar ActiveStar ActiveStar InactiveStar Inactive

Year 2023  

DCA390
DCA389
DCA388
DCA387
DCA386
DCA385
DCA384
DCA383
DCA382
DCA381
DCA380

 

Year 2022  

DCA379
DCA378  
DCA377
DCA376
DCA375
DCA374
DCA373
DCA372
DCA371  
DCA370
DCA369
DCA368

 

Year 2021     

DCA367
DCA366
DCA365
DCA363
DCA362
DCA361
DCA360
DCA359
DCA358
DCA357
DCA356
DCA355
DCA354
DCA353
DCA352


Year 2020 

DCA351
DCA350
DCA349
DCA348
DCA347
DCA346
DCA345
DCA344
DCA343
DCA342

 

Year 2019 

 
DCA341
DCA340
DCA339
DCA338
DCA337
DCA336
DCA335
DCA334
DCA333
DCA332
DCA331
DCA330

 

Year 2018 

DCA329
DCA328
DCA327
DCA326
DCA325
DCA324
DCA323
DCA322
DCA321
DCA320
DCA319
DCA319 Manual

 

Year 2017

DCA318
DCA318 (Manual)
DCA317
DCA316
DCA315
DCA314
DCA313
DCA312
DCA311
DCA310
DCA309
DCA308

 

 

New Products Approved Archived

Hits: 120713

User Rating: 3 / 5

Star ActiveStar ActiveStar ActiveStar InactiveStar Inactive

 

Approved Additional Indication DCA 390

Approved Additional Indication DCA 389

Approved Additional Indication DCA 388

Approved Additional Indication DCA 387

Approved Additional Indication DCA 386

Approved Additional Indication DCA 385

Approved Additional Indication DCA 384

Approved Additional Indication DCA 383

Approved Additional Indication DCA 382

Approved Additional Indication DCA 381

Approved Additional Indication DCA 380

Approved Additional Indication DCA 379

Approved Additional Indication DCA 378

Approved Additional Indication DCA 377

Approved Additional Indication DCA 376

Approved Additional Indication DCA 375

Approved Additional Indication DCA 374

Approved Additional Indication DCA 373

Approved Additional Indication DCA 372

Approved Additional Indication DCA 371  

Approved Additional Indication DCA 370

Approved Additional Indication DCA 369

Approved Additional Indication DCA 368

Approved Additional Indication DCA 367

Approved Additional Indication DCA 366

Approved Additional Indication DCA 365

Approved Additional Indication DCA 364 

Approved Additional Indication DCA 363

Approved Additional Indication DCA 362

Approved Additional Indication DCA 360

Approved Additional Indication DCA 359

Approved Additional Indication DCA 358

Approved Additional Indication DCA 357

Approved Additional Indication DCA 355

Approved Additional Indication DCA 354

Approved Additional Indication DCA 353

Approved Additional Indication DCA 352

Approved Additional Indication DCA 351

Approved Additional Indication DCA 350

Approved Additional Indication DCA 349

Approved Additional Indication DCA 348

Approved Additional Indication DCA 347

Approved Additonal Indication DCA 346

Approved Additional Indication DCA 344

Approved Additional Indication DCA 343

Approved Additional Indication DCA 342

Approved Additional Indication DCA 341

Approved Additional Indication DCA 340

Approved Additional Indication DCA 339

Approved Additional Indication DCA 338

Approved Additional Indication DCA 337

Approved Additional Indication DCA 336

Approved Additional Indication DCA 335

Approved Additional Indication DCA 334

Approved Additional Indication DCA 333

Approved Additional Indication DCA 332

Approved Additional Indication DCA 331

Approved Additional Indication DCA 330

Approved Additional Indication DCA 329

Approved Additional Indication DCA 328

Approved Additional Indication DCA 327

Approved Additional Indication DCA 326

Approved Additional Indication DCA 324

Approved Additional Indication DCA 323

Approved Additional Indication DCA 322

Approved Additional Indication DCA 321

Approved Additional Indication DCA 320

Approved Additional Indication DCA 319

Approved Additional Indication DCA 318

Approved Additional Indication DCA 317

Approved Additional Indication DCA 316

Approved Additional Indication DCA 315

Approved Additional Indication DCA 314

Approved Additional Indication DCA 313

Approved Additional Indication DCA 312

Approved Additional Indication DCA 310

Approved Additional Indication DCA 308

Approved Additional Indication DCA 307

Approved Additional Indication DCA 306

Approved Additional Indication DCA 305

Approved Additional Indication DCA 304

Approved Additional Indication DCA 303

Approved Additional Indication DCA 301

Approved Additional Indication DCA 300

Approved Additional Indication DCA 299

Approved Additional Indication DCA 295

Approved Additional Indication DCA 294

Approved Additional Indication DCA 293

Approved Additional Indication DCA 292

Approved Additional Indication DCA 291

Approved Additional Indication DCA 290

Approved Additional Indication DCA 289

Approved Additional Indication DCA 288

Approved Additional Indication DCA 287

Approved Additional Indication DCA 286

Approved Additional Indication DCA 284

Approved Additional Indication DCA 283

Approved Additional Indication DCA 282

Approved Additional Indication DCA 281

Approved Additional Indication DCA 280

Approved Additional Indication DCA 279

Approved Additional Indication DCA 277

Approved Additional Indication DCA 275

Approved Additional Indication DCA 274

Approved Additional Indication DCA 273

Approved Additional Indication DCA 272

Approved Additional Indication DCA 271

Approved Additional Indication DCA 269

Approved Additional Indication DCA 268

Approved Additional Indication DCA 267

Approved Additional Indication DCA 266

Approved Additional Indication DCA 265

Approved Additional Indication DCA 264

Approved Additional Indication DCA 263

Approved Additional Indication DCA 262

Approved Additional Indication DCA 261

Approved Additional Indication DCA 260

Approved Additional Indication DCA 259

Approved Additional Indication DCA 258

Approved Additional Indication DCA 257

Approved Additional Indication DCA 256

Approved Additional Indication DCA 253

Approved Additional Indication DCA 252

Approved Additional Indication DCA 250

Approved Additional Indication DCA 248

Additional Indications Approved / Archives

National Pharmaceutical Regulatory Agency (NPRA)

Lot 36, Jalan Universiti (Jalan Prof Diraja Ungku Aziz), 46200 Petaling Jaya, Selangor, Malaysia.

  • Phone: +603-7883 5400

 

 

Image   Image   Image   Image  

More Links

DISCLAIMER

The Government of Malaysia and the National Pharmaceutical Regulatory Agency are not responsible for any loss or damage caused by the usage of any information obtained from this website.

Mobile Web :

Site Last Modified

  • Last Modified: Friday 01 December 2023, 17:55:19.
© Copyright 2023 . All Rights Reserved National Pharmaceutical Regulatory Agency NPRA

Search

Main Menu English

Choose Your Language